Cloud Pharmaceuticals is changing the way drugs are discovered and developed. Cloud Pharmaceuticals designs new drugs and drug candidates and accelerates the development process by implementing new, innovative cloud computing technology in place of traditional methods. We manage development of multiple assets through an extensive network of partners. This reduces cost, decreases development time, and creates novel molecules with therapeutic value. Our drug discovery and development implementation consists of a drug design technology called Inverse Design that uses high-performance cloud computing resources, followed by immediate preclinical optimization and rapid development toward Investigational New Drug (IND) and Phase 1. We have a growing pipeline including central nervous system (CNS), cancer, inflammation, lipid metabolism, and rare disease indications, among others.